Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Clinical Trials

Business & Regulation Clinical Trials

Paranoid or Prepared?

| Angus Stewart

Stating an intention to be ready to win in any biowarzone, the US military has commissioned Dynavax to develop a vaccine for the plague.

Discovery & Development Clinical Trials

Please, Sir, May I Have Some Samples?

| Robert Hewitt

Biotech companies need good patient samples, but hospitals are not always obliging...

Discovery & Development Clinical Trials

Taking the Trial to the Patient

| Stephanie Sutton

The way the pharma industry has traditionally handled clinical trials does not make participation easy.

Business & Regulation Clinical Trials

Remembering Henrietta

| Maryam Mahdi

On the 70th anniversary of death Henrietta Lacks, we examine her contributions to science and what they mean for modern research.

Business & Regulation Standards & Regulation

Of Medicine and Machine Learning

| Angus Stewart, Stephanie Sutton

AI is expanding into medicine. Are the world’s regulators ready?

Discovery & Development Clinical Trials

Updates Ready: Reboot Necessary

| Temitope Keyes

Aging digital systems limit the potential of decentralized trials. It's time to rethink the technologies driving them.

Discovery & Development Clinical Trials

Malaysia in the Middle: Tackling Hep C in an Unfair World

| Angus Stewart

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

Manufacture Drug Discovery

Bringing Certainty to CAR T-Cell Discovery

| Jim Ross

How can we maximize the potential and production of potentially life-saving therapies?

Discovery & Development Clinical Trials

The Global Stage

| Claudia Berron

When it comes to conducting clinical trials in emerging geographies, there are four key challenges to consider.

Business & Regulation Standards & Regulation

The Winding Road to the Frontline for Advanced Therapies

| Angi Robinson

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register